JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
Standard
JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML. / Schnittger, S; Bacher, Ulrike; Kern, W; Haferlach, C; Haferlach, T.
in: LEUKEMIA, Jahrgang 21, Nr. 1, 1, 2007, S. 183-184.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
AU - Schnittger, S
AU - Bacher, Ulrike
AU - Kern, W
AU - Haferlach, C
AU - Haferlach, T
PY - 2007
Y1 - 2007
M3 - SCORING: Zeitschriftenaufsatz
VL - 21
SP - 183
EP - 184
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 1
M1 - 1
ER -